Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

218 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Stakeholders' perspectives on a patient-reported outcome measure-based drug safety monitoring system for immune-mediated inflammatory diseases.
Kosse LJ, Jessurun NT, Vonkeman HE, Tas SW, Nurmohamed MT, Hoentjen F, van Doorn MBA, van Puijenbroek EP, van den Bemt BJF, de Vries M. Kosse LJ, et al. Among authors: van doorn mba, van puijenbroek ep, van den bemt bjf. Expert Opin Drug Saf. 2020 Nov;19(11):1521-1528. doi: 10.1080/14740338.2020.1803826. Epub 2020 Aug 12. Expert Opin Drug Saf. 2020. PMID: 32730115
Clinical utility of therapeutic drug monitoring in biological disease modifying anti-rheumatic drug treatment of rheumatic disorders: a systematic narrative review.
Van Herwaarden N, Van Den Bemt BJF, Wientjes MHM, Kramers C, Den Broeder AA. Van Herwaarden N, et al. Among authors: van den bemt bjf, den broeder aa. Expert Opin Drug Metab Toxicol. 2017 Aug;13(8):843-857. doi: 10.1080/17425255.2017.1353602. Epub 2017 Jul 17. Expert Opin Drug Metab Toxicol. 2017. PMID: 28686523 Review.
Are Health Care Professionals' Implicit and Explicit Attitudes Toward Conventional Disease-Modifying Antirheumatic Drugs Associated With Those of Their Patients?
van Heuckelum M, Hebing RCF, Vandeberg L, Linn AJ, Flendrie M, Nurmohamed MT, van Dulmen S, van den Ende CHM, van den Bemt BJF. van Heuckelum M, et al. Among authors: van den ende chm, van dulmen s, van den bemt bjf. Arthritis Care Res (Hoboken). 2021 Mar;73(3):364-373. doi: 10.1002/acr.24186. Arthritis Care Res (Hoboken). 2021. PMID: 32166901
Patient-Reported Burden of Adverse Drug Reactions Attributed to Biologics Used for Immune-Mediated Inflammatory Diseases.
van Lint JA, Jessurun NT, Hebing RCF, Hoentjen F, Tas SW, Vonkeman HE, van Doorn MBA, Sobels A, Spuls PI, van Puijenbroek EP, Nurmohamed MT, van den Bemt BJF. van Lint JA, et al. Among authors: van doorn mba, van puijenbroek ep, van den bemt bjf. Drug Saf. 2020 Sep;43(9):917-925. doi: 10.1007/s40264-020-00946-z. Drug Saf. 2020. PMID: 32451974
Immune-mediated inflammatory disease patients' preferences in adverse drug reaction information regarding biologics.
Kosse LJ, Weits G, Vonkeman HE, Spuls PI, Van Den Bemt BJF, Tas SW, Hoentjen F, Nurmohamed MT, Van Doorn MBA, Van Puijenbroek EP, Jessurun NT. Kosse LJ, et al. Among authors: van doorn mba, van puijenbroek ep, van den bemt bjf. Expert Opin Drug Saf. 2020 Aug;19(8):1049-1054. doi: 10.1080/14740338.2020.1781090. Epub 2020 Jul 7. Expert Opin Drug Saf. 2020. PMID: 32524887
Gastrointestinal Adverse Drug Reaction Profile of Etanercept: Real-world Data From Patients and Healthcare Professionals.
van Lint JA, Jessurun NT, Tas SW, van den Bemt BJF, Nurmohamed MT, van Doorn MBA, Spuls PI, van Tubergen AM, Ten Klooster PM, van Puijenbroek EP, Hoentjen F, Vonkeman HE. van Lint JA, et al. Among authors: van doorn mba, van puijenbroek ep, van tubergen am, van den bemt bjf. J Rheumatol. 2021 Sep;48(9):1388-1394. doi: 10.3899/jrheum.201373. Epub 2021 May 15. J Rheumatol. 2021. PMID: 33993115
Hypoglycaemia following JAK inhibitor treatment in patients with diabetes.
van Lint JA, van Hunsel FPAM, Tas SW, Vonkeman HE, Hoentjen F, van Doorn MBA, Hebing RCF, Nurmohamed MT, van den Bemt BJF, van Puijenbroek EP, Jessurun NT. van Lint JA, et al. Among authors: van doorn mba, van puijenbroek ep, van hunsel fpam, van den bemt bjf. Ann Rheum Dis. 2022 Apr;81(4):597-599. doi: 10.1136/annrheumdis-2021-221840. Epub 2021 Dec 16. Ann Rheum Dis. 2022. PMID: 34916208 No abstract available.
218 results